Last reviewed · How we verify

Tramadol HCl-Paracetamol

Xian-Janssen Pharmaceutical Ltd. · FDA-approved active Small molecule

Tramadol HCl-Paracetamol is a Opioid analgesic combination Small molecule drug developed by Xian-Janssen Pharmaceutical Ltd.. It is currently FDA-approved for Moderate pain management, Post-operative pain, Musculoskeletal pain.

This combination drug reduces pain through dual action: tramadol inhibits monoamine reuptake and activates opioid receptors, while paracetamol inhibits prostaglandin synthesis.

This combination drug reduces pain through dual action: tramadol inhibits monoamine reuptake and activates opioid receptors, while paracetamol inhibits prostaglandin synthesis. Used for Moderate pain management, Post-operative pain, Musculoskeletal pain.

At a glance

Generic nameTramadol HCl-Paracetamol
SponsorXian-Janssen Pharmaceutical Ltd.
Drug classOpioid analgesic combination
TargetOpioid receptors (μ, δ, κ); monoamine transporters (norepinephrine, serotonin); cyclooxygenase enzymes
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Tramadol is a synthetic opioid agonist that also blocks the reuptake of norepinephrine and serotonin, enhancing pain modulation through multiple pathways. Paracetamol (acetaminophen) works as an analgesic and antipyretic by inhibiting cyclooxygenase enzymes and reducing prostaglandin production. Together, they provide synergistic analgesia for moderate pain relief.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tramadol HCl-Paracetamol

What is Tramadol HCl-Paracetamol?

Tramadol HCl-Paracetamol is a Opioid analgesic combination drug developed by Xian-Janssen Pharmaceutical Ltd., indicated for Moderate pain management, Post-operative pain, Musculoskeletal pain.

How does Tramadol HCl-Paracetamol work?

This combination drug reduces pain through dual action: tramadol inhibits monoamine reuptake and activates opioid receptors, while paracetamol inhibits prostaglandin synthesis.

What is Tramadol HCl-Paracetamol used for?

Tramadol HCl-Paracetamol is indicated for Moderate pain management, Post-operative pain, Musculoskeletal pain.

Who makes Tramadol HCl-Paracetamol?

Tramadol HCl-Paracetamol is developed and marketed by Xian-Janssen Pharmaceutical Ltd. (see full Xian-Janssen Pharmaceutical Ltd. pipeline at /company/xian-janssen-pharmaceutical-ltd).

What drug class is Tramadol HCl-Paracetamol in?

Tramadol HCl-Paracetamol belongs to the Opioid analgesic combination class. See all Opioid analgesic combination drugs at /class/opioid-analgesic-combination.

What development phase is Tramadol HCl-Paracetamol in?

Tramadol HCl-Paracetamol is FDA-approved (marketed).

What are the side effects of Tramadol HCl-Paracetamol?

Common side effects of Tramadol HCl-Paracetamol include Nausea, Dizziness, Constipation, Headache, Somnolence, Vomiting.

What does Tramadol HCl-Paracetamol target?

Tramadol HCl-Paracetamol targets Opioid receptors (μ, δ, κ); monoamine transporters (norepinephrine, serotonin); cyclooxygenase enzymes and is a Opioid analgesic combination.

Related